Newly Diagnosed High-Grade Glioma Surgery with Carmustine Wafers Implantation. A Long-Term Nationwide Retrospective Study - Aix-Marseille Université
Article Dans Une Revue World Neurosurgery Année : 2023

Newly Diagnosed High-Grade Glioma Surgery with Carmustine Wafers Implantation. A Long-Term Nationwide Retrospective Study

Charles Champeaux-Depond
Vincent Jecko
Joconde Weller
Panayotis Constantinou
Philippe Tuppin
Philippe Métellus
  • Fonction : Auteur
  • PersonId : 942859
Institut de neurophysiopathologie

Résumé

Widespread use of carmustine wafers (CWs) to treat high-grade gliomas (HGG) has been limited by uncertainties about their efficacy. We sought to assess the outcome of patients after newly diagnosed HGG surgery with CW implantation and search for associated factors.

Domaines

Sciences du Vivant [q-bio] Cancer

Ludovic Leloup  : Connectez-vous pour contacter le contributeur

https://amu.hal.science/hal-04461096

Soumis le : vendredi 16 février 2024-08:42:22

Dernière modification le : dimanche 18 février 2024-03:33:10

Fichier non déposé

Dates et versions

hal-04461096 , version 1 (16-02-2024)

Identifiants

Citer

Charles Champeaux-Depond, Vincent Jecko, Joconde Weller, Panayotis Constantinou, Philippe Tuppin, et al.. Newly Diagnosed High-Grade Glioma Surgery with Carmustine Wafers Implantation. A Long-Term Nationwide Retrospective Study. World Neurosurgery, 2023, 173, pp.e778-e786. ⟨10.1016/j.wneu.2023.03.015⟩. ⟨hal-04461096⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS UNIV-AMU INP NEUROMARSEILLE
31 Consultations
0 Téléchargements

Altmetric

Partager

More